Expression of CDX2 in benign tissue and adenocarcinoma of the prostate

Human Pathology

Volumn 38, Issue 1, 2007, Pages 72-78

  Herawi, Mehsati ^a   DeMarzo, Angelo M ^a   Kristiansen, Glen ^a   Epstein, Jonathan I ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Benign prostate; CDX2; Immunohistochemistry; Prostatic adenocarcinoma; Tissue microarray

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR CDX2;

ADULT; AGED; ARTICLE; CANCER GRADING; COLON MUCOSA; COMPARATIVE STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; METASTASIS; NEEDLE BIOPSY; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROTEIN EXPRESSION; STAINING; TISSUE MICROARRAY; TISSUE SECTION;

ADENOCARCINOMA; AGED, 80 AND OVER; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 33845331763     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.06.015     Document Type: Article

References (41)

1. Guo R.J., Suh E.R., and Lynch J.P. The role of Cdx proteins in intestinal development and cancer. Cancer Biol Ther 3 (2004) 593-601
2. Kaimaktchiev V., Terracciano L., Tornillo L., et al. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Mod Pathol 17 (2004) 1392-1399
3. van den Akker E., Forlani S., Chawengsaksophak K., et al. Cdx1 and Cdx2 have overlapping functions in anteroposterior patterning and posterior axis elongation. Development 129 (2002) 2181-2193
4. Barbareschi M., Roldo C., Zamboni G., et al. CDX-2 homeobox gene product expression in neuroendocrine tumors: its role as a marker of intestinal neuroendocrine tumors. Am J Surg Pathol 28 (2004) 1169-1176
5. De Lott L.B., Morrison C., Suster S., et al. CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites. Arch Pathol Lab Med 129 (2005) 1100-1105
6. Li M.K., and Folpe A.L. CDX-2, a new marker for adenocarcinoma of gastrointestinal origin. Adv Anat Pathol 11 (2004) 101-105
7. Sivagnanasundaram S., Islam I., Talbot I., et al. The homeobox gene CDX2 in colorectal carcinoma: a genetic analysis. Br J Cancer 84 (2001) 218-225
8. Werling R.W., Yaziji H., Bacchi C.E., et al. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol 27 (2003) 303-310
9. Barbareschi M., Murer B., Colby T.V., et al. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol 27 (2003) 141-149
10. Fraggetta F., Pelosi G., Cafici A., et al. CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours. Virchows Arch 443 (2003) 782-786
11. Logani S., Oliva E., Arnell P.M., et al. Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma. Mod Pathol 18 (2005) 19-25
12. Moskaluk C.A., Zhang H., Powell S.M., et al. Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod Pathol 16 (2003) 913-919
13. Dennis J.L., Hvidsten T.R., Wit E.C., et al. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res 11 (2005) 3766-3772
14. Nunes F.D., de Almeida F.C., Tucci R., and de Sousa S.C. Homeobox genes: a molecular link between development and cancer. Pesqui Odontol Bras 17 (2003) 94-98
15. Taylor J.K., Levy T., Suh E.R., and Traber P.G. Activation of enhancer elements by the homeobox gene Cdx2 is cell line specific. Nucleic Acids Res 25 (1997) 2293-2300
16. Saad R.S., Cho P., Silverman J.F., and Liu Y. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma. Am J Clin Pathol 122 (2004) 421-427
17. Cathro H.P., and Mills S.E. Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2. Am J Surg Pathol 28 (2004) 1026-1032
18. Franchi A., Massi D., Palomba A., et al. CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract. Virchows Arch 445 (2004) 63-67
19. Mazziotta R.M., Borczuk A.C., Powell C.A., and Mansukhani M. CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall. Appl Immunohistochem Mol Morphol 13 (2005) 55-60
20. Raspollini M.R., Amunni G., Villanucci A., et al. Utility of CDX-2 in distinguishing between primary and secondary (intestinal) mucinous ovarian carcinoma: an immunohistochemical comparison of 43 cases. Appl Immunohistochem Mol Morphol 12 (2004) 127-131
21. Tornillo L., Moch H., Diener P.A., Lugli A., and Singer G. CDX-2 immunostaining in primary and secondary ovarian carcinomas. J Clin Pathol 57 (2004) 641-643
22. La Rosa S., Rigoli E., Uccella S., et al. CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors. Virchows Arch 445 (2004) 248-254
23. Mesquita P., Almeida R., Van Seuningen I., and David L. Coordinated expression of MUC2 and CDX-2 in mucinous carcinomas of the lung can be explained by the role of CDX-2 as transcriptional regulator of MUC2. Am J Surg Pathol 28 (2004) 1254-1255
24. Rossi G., Murer B., Cavazza A., et al. Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression. Am J Surg Pathol 28 (2004) 442-452
25. Yamamoto H., Bai Y.Q., and Yuasa Y. Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression. Biochem Biophys Res Commun 300 (2003) 813-818
26. Del Bene F., and Wittbrodt J. Cell cycle control by homeobox genes in development and disease. Semin Cell Dev Biol 16 (2005) 449-460
27. Du H., and Taylor H.S. Molecular regulation of mullerian development by Hox genes. Ann N Y Acad Sci 1034 (2004) 152-165
28. Grier D.G., Thompson A., Kwasniewska A., et al. The pathophysiology of HOX genes and their role in cancer. J Pathol 205 (2005) 154-171
29. Rawat V.P., Cusan M., Deshpande A., et al. Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia. Proc Natl Acad Sci U S A 101 (2004) 817-822
30. Economides K.D., and Capecchi M.R. Hoxb13 is required for normal differentiation and secretory function of the ventral prostate. Development 130 (2003) 2061-2069
31. Miller G.J., Miller H.L., van Bokhoven A., et al. Aberrant HOXC expression accompanies the malignant phenotype in human prostate. Cancer Res 63 (2003) 5879-5888
32. Shen M.M., and Abate-Shen C. Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis. Dev Dyn 228 (2003) 767-778
33. 3 modulated gene expression patterns in human primary normal and cancer prostate cells. J Cell Biochem 93 (2004) 271-285
34. Hayes V.M., Severi G., Padilla E.J., et al. Genetic variants in the vitamin D receptor gene and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 14 (2005) 997-999
35. John E.M., Schwartz G.G., Koo J., et al. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res 65 (2005) 5470-5479
36. Tokar E.J., and Webber M.M. Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells. Clin Exp Metastasis 22 (2005) 275-284
37. Arai H., Miyamoto K.I., Yoshida M., et al. The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene. J Bone Miner Res 16 (2001) 1256-1264
38. Yamamoto H., Miyamoto K., Li B., et al. The caudal-related homeodomain protein Cdx-2 regulates vitamin D receptor gene expression in the small intestine. J Bone Miner Res 14 (1999) 240-247
39. Hoenderop J.G., Nilius B., and Bindels R.J. Epithelial calcium channels: from identification to function and regulation. Pflugers Arch 446 (2003) 304-308
40. 2+ transport and beyond. J Physiol 551 (2003) 729-740
41. 2+ channel expression. Biochem Biophys Res Commun 322 (2004) 1359-1363